Battery failures cost the EV industry $5B+ annually in warranty claims, recalls, and safety incidents. Modern electric vehicles generate millions of telemetry points daily from battery management ...
The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...
Unstructured announced today it has been awarded a $2 million Tactical Funding Increase (TACFI) contract by AFWERX in partnership with the U.S. Air Force Test Center’s (AFTC) 96th Test Wing. Building ...
SAN FRANCISCO--(BUSINESS WIRE)--Unstructured announced today it has been awarded a $2 million Tactical Funding Increase (TACFI) contract by AFWERX in partnership with the U.S. Air Force Test Center’s ...
CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise. The Framework Desktop is an interesting machine. It offers ...
NEW YORK – Quanterix said Tuesday that it has submitted a 510(k) premarket notification to the US Food and Drug Administration for its Lucent AD Complete multi-analyte algorithmic blood test for ...
One of the most pressing challenges to the continued deployment of nuclear energy systems is in the ultimate management and disposition of discharged fuel assemblies. While reprocessing and recovery ...
Your source for the latest in AI Native Development — news, insights, and real-world developer experiences. Your source for the latest in AI Native Development — news, insights, and real-world ...
Non-animal framework based on new approach methodologies (NAMs) for chemical hazard identification and risk assessment. The framework comprises three modules: (1) high-throughput screening to address ...
TL;DR: Trump’s surprise hemp ban doesn’t just wipe out a massive part of the hemp-derived market; it may also create the legal framework for a broader federal crackdown on cannabis. With the Heritage ...
The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results